Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating cat fatty liver and preparation method thereof

A composition and drug technology, which can be used in drug combinations, pharmaceutical formulations, and medical preparations containing active ingredients, etc., can solve problems such as unsatisfactory curative effect and curing symptoms rather than root causes.

Inactive Publication Date: 2016-05-04
SHANGHAI TRUELAND INFORMATION & TECH CO LTD
View PDF22 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although it can temporarily delay the disease, it treats the symptoms but not the root cause, and the curative effect is not satisfactory

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for treating cat fatty liver and preparation method thereof
  • Pharmaceutical composition for treating cat fatty liver and preparation method thereof
  • Pharmaceutical composition for treating cat fatty liver and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0062] The invention also provides a preparation method of the pharmaceutical composition.

[0063] A preparation method of a pharmaceutical composition, comprising

[0064] Step 1: According to the ratio of raw materials, weigh the root-pulling vegetables, Eucommia, Comfrey, Tribulus terrestris, Polygonum cuspidatum, Paradise grass, raw rhubarb, and cassia seeds, grind them, reflux extraction after cold soaking in ethanol, and collect the filtrate by filtration;

[0065] Step 2: According to the proportion of raw materials, weigh and crush the leaves, melon pedicles, Ligustrum lucidum, thistle, kudzu flower, capillary, turmeric, Bupleurum, Alisma, pinellia, tangerine peel, and peach kernel, and collect after water extraction filtrate;

[0066] Step 3: Combine the filtrate obtained in step 1 with the filtrate obtained in step 2, and add choline chloride powder and ursodeoxycholic acid tablets according to the proportion.

[0067] The ethanol cold soaking and reflux extractio...

Embodiment 1

[0085] Embodiment 1: pharmaceutical composition of the present invention

[0086] 60 parts of Phyllostachys chinensis, 60 parts of root vegetables, 60 parts of melon stalks, 50 parts of Ligustrum lucidum, 50 parts of Eucommia, 50 parts of comfrey, 50 parts of kudzu flower, 50 parts of Polygonum cuspidatum, 40 parts of Tribulus terrestris, 40 parts of thistle, 40 parts of capillary, 40 parts of paradise grass, 40 parts of turmeric, 40 parts of raw rhubarb, 40 parts of Bupleurum, 35 parts of Alisma, 35 parts of pinellia, 35 parts of cassia seed, 35 parts of tangerine peel, 30 parts of peach kernel, cholerin 20 parts of alkali powder, 4 parts of ursodeoxycholic acid tablets.

Embodiment 2

[0087] Embodiment 2: pharmaceutical composition of the present invention

[0088] 40 parts of Phyllostachys foliage, 40 parts of root vegetables, 40 parts of melon stalks, 30 parts of Ligustrum lucidum, 30 parts of Eucommia, 30 parts of comfrey, 30 parts of kudzu flower, 30 parts of Polygonum cuspidatum, 20 parts of Tribulus terrestris, 20 parts of thistle, 20 parts capillary, 20 parts paradise grass, 20 parts turmeric, 20 parts raw rhubarb, 20 parts Bupleurum, 15 parts Alisma, 15 parts pinellia, 15 parts cassia seed, 15 parts tangerine peel, 10 parts peach kernel, bile chloride 20 parts of alkali powder, 4 parts of ursodeoxycholic acid tablets.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of veterinary drugs, and discloses a pharmaceutical composition for treating cat fatty liver as well as a preparation method and application thereof. The pharmaceutical composition is prepared from the raw materials of herba phyllanthi urinariae, clethra loosestrife herb, muskmelon base, glossy privet fruit, eucommia bark, Sinkiang arnebia root, white puncturevine caltrop fruit, common cephalanoplos herb, flower of lobed kudzuvine, giant knotweed rhizome, capillary wormwood herb, tiflawn, turmeric root-tuber, raw rhubarb, Chinese thorowax root, oriental waterplantain rhizome, pinellia tuber, cassia seed, tangerine peel, peach seed, choline chloride, and ursodesoxycholic acid according to certain weight parts. The pharmaceutical composition is simple in formula, has significant effects of clearing heat, removing fat, protecting the liver, dissipating blood stasis, excreting dampness, invigorating the spleen, promoting the circulation of qi, reducing phlegm, arresting bleeding, and soothing the liver to remove fat by virtue of organic combination, dialectic compatibility and mutual assistance, and can be used for effectively treating cat fatty liver syndromes. Clinical treatment statistics prove that the cure rate can reach 88.89%, and the effective rate is 100%. The preparation method of the pharmaceutical composition disclosed by the invention keeps active ingredients of each raw material to the maximum extent and is simple to operate, and the pharmaceutical composition does not have toxic or side effects, is easy to absorb by a diseased cat, and is suitable for industrial production.

Description

technical field [0001] The invention relates to the technical field of veterinary medicine, in particular to a pharmaceutical composition for treating fatty liver in cats, a preparation method and application thereof. Background technique [0002] Feline fatty liver syndrome is a disease in which the liver enlarges due to lipid storage in liver cells. Because the cat's liver has a special ability to accumulate fat, the disease is specific to cats and can easily cause liver cell damage. Clinical data prove that feline fatty liver syndrome is the most common liver disease in cats. Most cats with fatty liver develop liver disease, which is the most common form of liver disease in cats. Fatty liver disease in cats is more serious than that in dogs, and it often leads to death if it is not treated in time. Feline fatty liver syndrome does not distinguish between breeds. The incidence rate of female cats is higher than that of male cats. They do not eat food for a period of tim...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9066A61P1/16A61K31/14A61K31/575
CPCA61K36/47A61K31/14A61K31/575A61K36/185A61K36/233A61K36/28A61K36/282A61K36/30A61K36/42A61K36/46A61K36/482A61K36/488A61K36/638A61K36/704A61K36/708A61K36/736A61K36/752A61K36/884A61K36/8888A61K36/899A61K36/9066A61K2236/331A61K2236/333A61K2236/39A61K2300/00
Inventor 王开
Owner SHANGHAI TRUELAND INFORMATION & TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products